Procter & Gamble's acquisition of the consumer health business of Merck KGaA has gotten the all-clear from the European Commission, the EU body said Tuesday.
The unit specializes in the production, marketing and sales of over-the-counter drugs. Procter & Gamble, meanwhile, is a global manufacturer of consumer goods, ranging from household care to grooming supplies.
In a statement, the commission said the sale would not pose competition concerns because the businesses of the two companies "are generally complementary."
Darmstadt-based Merck announced the sale, amounting to 3.4 billion euros (3.98 billion dollars), in April.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.
